🗂️
Archived grant — no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
grant
Children's Oncology Group Statistics and Data Center
Organization UNIVERSITY OF SOUTHERN CALIFORNIALocation Los Angeles, UNITED STATESPosted 1 Mar 2023Deadline 28 Feb 2026 ⚠️
NIHUS FederalResearch GrantFY20250-11 years old1 year of age1 year oldAML - Acute Myeloid LeukemiaAccelerationAcuteAcute Myeloblastic LeukemiaAcute Myelocytic LeukemiaAcute Myelogenous LeukemiaAdolescentAdolescent YouthAdverse Late EffectsAustraliaBody TissuesBrain Stem GliomaBrain Stem Neuroglial NeoplasmBrain Stem Neuroglial TumorBrainstem GliomaBrainstem Neuroglial NeoplasmBrainstem Neuroglial TumorCanadaCancer CenterCancer PatientCancer TreatmentCancersCaringCause of DeathCell TherapyChildChild SupportChild YouthChildhoodChildhood CancersChildhood LeukemiaChildren (0-21)Children's HospitalChildren's Oncology GroupClinicalClinical ResearchClinical StudyClinical TrialsClinical Trials DesignCollaborationsCollectionCommunitiesComplicationCountryDevelopmentDiagnosisDiseaseDisorderDoseDrugsDysfunctionEligibilityEligibility DeterminationEnrollmentEnsureFamilyFoundationsFunctional disorderGenerationsGoalsHormonalImmune mediated therapyImmunologically Directed TherapyImmunotherapyInfrastructureInstitutionInterdisciplinary ResearchInterdisciplinary StudyInvestigatorsKnowledgeLaboratoriesLate EffectsLeadMalignant Childhood NeoplasmMalignant Childhood TumorMalignant Neoplasm TherapyMalignant Neoplasm TreatmentMalignant NeoplasmsMalignant Pediatric NeoplasmMalignant Pediatric TumorMalignant TumorMalignant childhood cancerMedicationMethodsMissionMolecularMorbidityMorbidity - disease rateMultidisciplinary CollaborationMultidisciplinary ResearchNCI OrganizationNational Cancer InstituteNational Clinical Trials NetworkNeuroblastomaNew ZealandOrganOrganization ChartsOrphan DiseaseOutcomePatientsPb elementPediatric HospitalsPediatric LeukemiaPediatric Oncology GroupPharmaceutical PreparationsPhysiopathologyPopulation HeterogeneityPopulation ResearchPopulation-based researchPopulation-level researchPositionPositioning AttributeProductivityPrognosisProtocol ScreeningQOLQOL improvementQuality of lifeRare DiseasesRare DisorderResearchResearch PersonnelResearchersScientistSecond CancerSecond Primary CancersSecondary MalignancySecondary Malignant NeoplasmSiteSurvival RateSurvivorsTissuesTranslational ResearchTranslational ScienceUnited StatesUniversitiesWorkacute granulocytic leukemiaacute myeloid leukemiaage 1 yearaged 1 yearaged one yearanti-cancer researchanti-cancer therapycancer diagnosiscancer in a childcancer in childrencancer researchcancer therapycancer-directed therapycell based interventioncell mediated interventioncell mediated therapiescell-based therapeuticcell-based therapycellular therapeuticcellular therapychemotherapychild with cancerchildhood cancer survivorchildhood malignancychildren with leukemiaclinical translationclinically translatabledata centersdesigndesigningdevelopmentaldiverse populationsdrug/agentenrollexperiencehealth related quality of lifeheavy metal Pbheavy metal leadheterogeneous populationhigh riskimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based therapiesimmune-based treatmentsimmuno therapyimprovedimproved outcomeimprovements in QOLimprovements in quality of lifeinnovateinnovationinnovativejuvenilejuvenile humankidsleukemia in childrenmalignancymembermultidisciplinaryneoplasm/cancernew therapeutic approachnew therapeutic interventionnew therapeutic strategiesnew therapy approachesnew treatment approachnew treatment strategynovel therapeutic approachnovel therapeutic interventionnovel therapeutic strategiesnovel therapy approachone year of ageone year oldoperationoperationsorganizational structureorphan disorderpathophysiologypediatricpediatric cancerpediatric cancer survivorpediatric malignancypopulation diversityquality of life improvementreproductivesecondary cancersmall moleculestatisticssuccesssurvivorshiptranslation researchtranslational investigationtranslational studyyoungster
Applications closed.
Description preview
PROJECT SUMMARY
Since the introduction of chemotherapy for the treatment of childhood leukemia more than 60 years ago, the
prognosis of childhood cancer has improved dramatically. The overall 5-year survival rate for childhood cancers,
many of which were uniformly fatal in the pre-chemotherapy era, is now 84%. Progress for a number of childhood…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click